In terms of pathology, it is well accepted that in early stages, neural damage arises from T-cell-mediated autoimmunity targeted against the major constituents of the myelin sheath, such as myelin proteolipid protein (PLP). This evidence concerns the gene PLP1 and Autoimmunity.